Reduced Expression of DNA Repair and Redox Signaling Protein APE1/Ref-1 Impairs Human Pancreatic Cancer Cell Survival, Proliferation, and Cell Cycle Progression

REFERENCES

• Moore, M.J. Chemotherapy in pancreatic carcinoma. Current Oncol 2003, 5, s24–s26.
   Google Scholar
• Duffy, J.P.; Eibl, G.; Reber, H.A.; Hines, O.J. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer 2003, 2, 12.
   PubMedGoogle Scholar
• Zou, G.M.; Maitra, A. Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration. Mol Cancer Ther 2008, 7, 2012–2021.
   PubMed Web of Science ®Google Scholar
• Evans, A.R.; Limp-Foster, M.; Kelley, M.R. Going APE over ref-1. Mutat Res 2000, 461, 83–108.
   PubMed Web of Science ®Google Scholar
• Tell, G.; Quadrifoglio, F.; Tiribelli, C.; Kelley, M.R. The many functions of APE1/Ref-1: not only a DNA repair enzyme. Antioxid Redox Signal 2009, 11, 601–620.
   PubMed Web of Science ®Google Scholar
• Xie, K.; Wei, D.; Huang, S. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006, 17, 147–156.
   PubMed Web of Science ®Google Scholar
• Ray, S.; Lee, C.; Hou, T.; Bhakat, K.K.; Brasier, A.R. Regulation of signal transducer and activator of transcription 3 enhanceosome formation by apurinic/apyrimidinic endonuclease 1 in hepatic acute phase response. Mol Endocrinol 2010, 24, 391–401.
   Google Scholar
• Luo, M.; Delaplane, S.; Jiang, A.; Reed, A.; He, Y.; Fishel, M.; Nyland RL, 2nd; Borch, R.F.; Qiao, X.; Georgiadis, M.M.; Kelley, M.R. Role of the multifunctional DNA repair and redox signaling protein Ape1/Ref-1 in cancer and endothelial cells: small-molecule inhibition of the redox function of Ape1. Antioxid Redox Signal 2008, 10, 1853–1867.
   PubMed Web of Science ®Google Scholar
• Zou, G.M.; Karikari, C.; Kabe, Y.; Handa, H.; Anders, R.A.; Maitra, A. The Ape-1/Ref-1 redox antagonist E3330 inhibits the growth of tumor endothelium and endothelial progenitor cells: therapeutic implications in tumor angiogenesis. J Cell Physiol 2009, 219, 209–218.
   Google Scholar
• Bhakat, K.K.; Mantha, A.K.; Mitra, S. Transcriptional regulatory functions of mammalian AP-endonuclease (APE1/Ref-1), an essential multifunctional protein. Antioxid Redox Signal 2009, 11, 621–638.
   PubMed Web of Science ®Google Scholar
• Bapat, A.; Fishel, M.; Kelley, M.R. Going Ape as an approach to cancer therapeutics. Antioxid Redox Signal 2009, 11, 651–668.
   PubMed Web of Science ®Google Scholar
• Fishel, M.L.; Kelley, M.R. The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target. Molecular Aspects of Medicine 2007, 28, 375–395.
   PubMed Web of Science ®Google Scholar
• Jiang, Y.; Guo, C.; Vasko, M.R.; Kelley, M.R. Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Res 2008, 68, 6425–6434.
   PubMed Web of Science ®Google Scholar
• Walker, L.J.; Craig, R.B.; Harris, A.L.; Hickson, I.D. A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 1994, 22, 4884–4889.
   PubMed Web of Science ®Google Scholar
• Lau, J.P.; Weatherdon, K.L.; Skalski, V.; Hedley, D.W. Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides. Br J Cancer 2004, 91, 1166–1173.
   Google Scholar
• Wang, D.; Luo, M.; Kelley, M.R. Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther 2004, 3, 679–686.
   PubMed Web of Science ®Google Scholar
• Fan, Z.; Beresford, P.J.; Zhang, D.; Xu, Z.; Novina, C.D.; Yoshida, A.; Pommier, Y.; Lieberman, J. Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A. Nat Immunol 2003, 4, 145–153.
   PubMed Web of Science ®Google Scholar
• Fishel, M.L.; He, Y.; Reed, A.M.; Chin-Sinex, H.; Hutchins, G.D.; Mendonca, M.S.; Kelley, M.R. Knockdown of the DNA repair and redox signaling protein Ape1/Ref-1 blocks ovarian cancer cell and tumor growth. DNA Repair (Amst) 2008, 7, 177–186.
   PubMed Web of Science ®Google Scholar
• Moore, D.H.; Michael, H.; Tritt, R.; Parsons, S.H.; Kelley, M.R. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers. Clin Cancer Res 2000, 6, 602–609.
   PubMed Web of Science ®Google Scholar
• Tell, G.; Pellizzari, L.; Pucillo, C.; Puglisi, F.; Cesselli, D.; Kelley, M.R.; Di Loreto, C.; Damante, G. TSH controls Ref-1 nuclear translocation in thyroid cells. J Mol Endocrinol 2000, 24, 383–390.
   PubMed Web of Science ®Google Scholar
• Hansen, W.K.; Deutsch, W.A.; Yacoub, A.; Xu, Y.; Williams, D.A.; Kelley, M.R. Creation of a fully functional human chimeric DNA repair protein. Combining O6-methylguanine DNA methyltransferase (MGMT) and AP endonuclease (APE/redox effector factor 1 (Ref 1)) DNA repair proteins. J Biol Chem 1998, 273, 756–762.
   PubMed Web of Science ®Google Scholar
• Robertson, K.A.; Hill, D.P.; Xu, Y.; Liu, L.; Van Epps, S.; Hockenbery, D.M.; Park, J.R.; Wilson, T.M.; Kelley, M.R. Down-regulation of apurinic/apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ 1997, 8, 443–449.
   PubMedGoogle Scholar
• Xu, Y.; Moore, D.H.; Broshears, J.; Liu, L.; Wilson, T.M.; Kelley, M.R. The apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 1997, 17, 3713–3719.
   PubMed Web of Science ®Google Scholar
• Fishel, M.L.; Newell, D.R.; Griffin, R.J.; Davison, R.; Wang, L.Z.; Curtin, N.J.; Zuhowski, E.G.; Kasza, K.; Egorin, M.J.; Moschel, R.C.; Dolan, M.E. Effect of cell cycle inhibition on Cisplatin-induced cytotoxicity. J Pharmacol Exp Ther 2005, 312, 206–213.
   PubMed Web of Science ®Google Scholar
• Arris, C.E.; Boyle, F.T.; Calvert, A.H.; Curtin, N.J.; Endicott, J.A.; Garman, E.F.; Gibson, A.E.; Golding, B.T.; Grant, S.; Griffin, R.J.; Jewsbury, P.; Johnson, L.N.; Lawrie, A.M.; Newell, D.R.; Noble, M.E.; Sausville, E.A.; Schultz, R.; Yu, W. Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem 2000, 43, 2797–2804.
   PubMed Web of Science ®Google Scholar
• Dolan, M.E.; Chae, M.Y.; Pegg, A.E.; Mullen, J.H.; Friedman, H.S.; Moschel, R.C. Metabolism of O6-benzylguanine, an inactivator of O6-alkylguanine-DNA alkyltransferase. Cancer Res 1994, 54, 5123–5130.
   Google Scholar
• Dolan, M.E.; Roy, S.K.; Fasanmade, A.A.; Paras, P.R.; Schilsky, R.L.; Ratain, M.J. O6-benzylguanine in humans: metabolic, pharmacokinetic, and pharmacodynamic findings. J Clin Oncol 1998, 16, 1803–1810.
   PubMed Web of Science ®Google Scholar
• Szabados, E.; Fischer, G.M.; Gallyas, F., Jr.; Kispal, G.; Sumegi, B. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart. Free Radic Biol Med 1999, 27, 1103–1113.
   PubMed Web of Science ®Google Scholar
• Tell, G.; Damante, G.; Caldwell, D.; Kelley, M.R. The intracellular localization of APE1/Ref-1: more than a passive phenomenon? Antioxid Redox Signal 2005, 7, 367–384.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay, R.; Wiederhold, L.; Szczesny, B.; Boldogh, I.; Hazra, T.K.; Izumi, T.; Mitra, S. Identification and characterization of mitochondrial abasic (AP)-endonuclease in mammalian cells. Nucleic Acids Res 2006, 34, 2067–2076.
   PubMed Web of Science ®Google Scholar
• Anderson, S.; Bankier, A.T.; Barrell, B.G.; de Bruijn, M.H.; Coulson, A.R.; Drouin, J.; Eperon, I.C.; Nierlich, D.P.; Roe, B.A.; Sanger, F.; Schreier, P.H.; Smith, A.J.; Staden, R.; Young, I.G. Sequence and organization of the human mitochondrial genome. Nature 1981, 290, 457–465.
   PubMed Web of Science ®Google Scholar
• Fung, H.; Demple, B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell 2005, 17, 463–470.
   PubMed Web of Science ®Google Scholar
• Vascotto, C.; Cesaratto, L.; Zeef, L.A.; Deganuto, M.; D'Ambrosio, C.; Scaloni, A.; Romanello, M.; Damante, G.; Taglialatela, G.; Delneri, D.; Kelley, M.R.; Mitra, S.; Quadrifoglio, F.; Tell, G. Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics 2009, 9, 1058–1074.
   PubMed Web of Science ®Google Scholar
• Chow, J.P.; Siu, W.Y.; Ho, H.T.; Ma, K.H.; Ho, C.C.; Poon, R.Y. Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints. J Biol Chem 2003, 278, 40815–40828.
   PubMed Web of Science ®Google Scholar
• Dekoj, T.; Lee, S.; Desai, S.; Trevino, J.; Babcock, T.A.; Helton, W.S.; Espat, N.J. G2/M cell-cycle arrest and apoptosis by n-3 fatty acids in a pancreatic cancer model. J Surg Res 2007, 139, 106–112.
   PubMed Web of Science ®Google Scholar
• Ujiki, M.B.; Ding, X.Z.; Salabat, M.R.; Bentrem, D.J.; Golkar, L.; Milam, B.; Talamonti, M.S.; Bell RH, Jr.; Iwamura, T.; Adrian, T.E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 2006, 5, 76.
   PubMed Web of Science ®Google Scholar
• Moore, M.J.; Feld, R.; Hedley, D.; Oza, A.; Siu, L.L. A phase II study of temozolomide in advanced untreated pancreatic cancer. Invest New Drugs 1998, 16, 77–79.
   PubMed Web of Science ®Google Scholar
• Burris HA, 3rd. Recent updates on the role of chemotherapy in pancreatic cancer. Semin Oncol 2005, 32, 1–3.
   Google Scholar
• Kern, S.; Tempero, M.; Conley, B.; et al. Pancreatic Cancer: An Agenda for Action. Bethesda, MD: National Cancer Institute, 2001.
   Google Scholar
• Yang, S.; Misner, B.; Chiu, R.; Meyskens FL, Jr. Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells. Carcinogenesis 2007, 28, 2382–2390.
   PubMed Web of Science ®Google Scholar
• Mohiuddin, M.; Chendil, D.; Dey, S.; Alcock, R.A.; Regine, W.; Mohiuddin, M.; Ahmed, M.M. Influence of p53 status on radiation and 5-flourouracil synergy in pancreatic cancer cells. Anticancer Res 2002, 22, 825–830.
   PubMed Web of Science ®Google Scholar
• Yu, J.; Zhang, L.; Hwang, P.M.; Rago, C.; Kinzler, K.W.; Vogelstein, B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999, 96, 14517–14522.
   PubMed Web of Science ®Google Scholar
• Grau, A.M.; Zhang, L.; Wang, W.; Ruan, S.; Evans, D.B.; Abbruzzese, J.L.; Zhang, W.; Chiao, P.J. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 1997, 57, 3929–3934.
   PubMed Web of Science ®Google Scholar
• Ewald, B.; Sampath, D.; Plunkett, W. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol Cancer Ther 2007, 6, 1239–1248.
   PubMed Web of Science ®Google Scholar
• Sorensen, C.S.; Syljuasen, R.G.; Falck, J.; Schroeder, T.; Ronnstrand, L.; Khanna, K.K.; Zhou, B.B.; Bartek, J.; Lukas, J. Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 2003, 3, 247–258.
   PubMed Web of Science ®Google Scholar
• Marcelino, L.A.; Thilly, W.G. Mitochondrial mutagenesis in human cells and tissues. Mutat Res 1999, 434, 177–203.
   PubMed Web of Science ®Google Scholar
• Luo, M.; He, H.; Kelley, M.R.; Georgiadis, M. Redox regulation of DNA repair: implications for human health and cancer therapeutic development. Antioxid Redox Signal 2010, 12, 1247–1269.
   PubMed Web of Science ®Google Scholar
• Liu, L.; Gerson, S.L. Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Curr Opin Investig Drugs 2004, 5, 623–627.
   PubMedGoogle Scholar
• Madhusudan, S.; Smart, F.; Shrimpton, P.; Parsons, J.L.; Gardiner, L.; Houlbrook, S.; Talbot, D.C.; Hammonds, T.; Freemont, P.A.; Sternberg, M.J.; Dianov, G.L.; Hickson, I.D. Isolation of a small molecule inhibitor of DNA base excision repair. Nucleic Acids Res 2005, 33, 4711–4724.
   PubMed Web of Science ®Google Scholar